New form of severe childhood obesity with high mortality discovered
A newly discovered gene mutation can cause syndromic obesity at a young age, accompanied by muscle weakness, cognitive problems & high mortality.
Advancing healthcare education and clinical practice with extended reality (XR)
In the ever-evolving healthcare landscape, technology plays an indispensable role in shaping the future of medical education and clinical practice.
One step closer to personalised ovarian cancer treatments
New research uncovers reasons for relapse and treatment resistance in ovarian high grade serous cancer.
In Memoriam: Professor Paul David Abel
Paul David Abel 1952 - 2023.
Study reveals need for early diagnosis and treatment of liver disease in Africa
Research, published in The Lancet Global Health, highlights the urgent need for interventions & early screening programs for liver disease in Africa.
Imperial and Visible launch app-based health studies into Long COVID
Patient-led start-up Visible has launched two app-based health studies in collaboration with researchers at Imperial College London.
Study shows real-world COVID-19 vaccine response in vulnerable patient groups
Data from the OCTAVE study show for the first time COVID-19 vaccine responses for people with immunocompromised or immunosuppressed conditions.
Cholesterol guidelines and menstrual cycle insights: News from the College
Here’s a batch of fresh news and announcements from across Imperial.
Study highlights the complex & variable nature of ovarian cancer tumour biology
A new study highlights the unique nature of ovarian cancer and the extent of variability between patients.
New Organoid Facility for cutting-edge disease modelling and precision medicine
A new Imperial Facility will be a central research and technology hub to develop human stem cell-based disease models, called organoids.
